RxDoctor Payments Data

Raymond Winicki, MD

Otolaryngology · Waterbury, CTNPI 1720083421

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,967 of the $6,414 with a category attached, or 61.9%. 25 manufacturers reported payments, led by Intersect ENT, Inc. at 45.9% of the total. Reporting peaked in 2019 at $2,742 and has fallen 62.1% since, to $1,038 in 2025. Among otolaryngology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,414in general payments, 2019–2025

Across 133 payments — averaging $48.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$3K
  • Medical Device Business Services, Inc.$883
  • GSK$531
  • Regeneron Healthcare Solutions, Inc.$368
  • Optinose US, Inc.$345
  • Genentech USA, Inc.$144
  • plus $1K from 19 others

What the payments were for

  • Travel & lodging$2,41338%
  • Food & beverage$3,96762%
  • Education$341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,414 in reported general payments places this provider in the 90th percentile of 119 otolaryngology providers in Connecticut.

See all otolaryngology providers in Connecticut

Medicare billing

Part B allowed, 2024
$266,043
Medicare patients
868
Services billed
4,515

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab35$144,913
Azelastine-FluticasoneAzelastine/Fluticasone132$12,773
Azelastine Hcl251$6,617
Fluticasone Propionate180$2,883
Fluocinolone Acetonide Oil63$2,687
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth26$2,208
Mometasone Furoate17$1,631
Esomeprazole Magnesium15$1,604
Ofloxacin16$1,085
Famotidine103$1,038
Cefdinir65$1,028
Ipratropium Bromide33$877
Pantoprazole Sodium150$859
Montelukast Sodium38$558
Methylprednisolone77$438

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Waterbury

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →